Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Di Perri

Showing results (291-300 of 358) with videos related to

Pageof 36
Sort By:
Antioxidants (Basel, Switzerland)|May 27, 2023
COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress GeneticsJessica Cusato, Alessandra Manca, Alice Palermiti, et al.
Pharmaceuticals (Basel, Switzerland)|December 30, 2020
Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIVAmedeo De Nicolò, Alice Ianniello, Micol Ferrara, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene VariantsJessica Cusato, Alice Palermiti, Alessandra Manca, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
The cerebrospinal fluid virome in people with HIV: links to neuroinflammation and cognitionMattia Trunfio, Rossana Scutari, Valeria Fox, et al.
Frontiers in Microbiology|November 20, 2025
The cerebrospinal fluid virome in people with HIV: links to neuroinflammation and cognitionMattia Trunfio, Rossana Scutari, Valeria Fox, et al.
Antimicrobial Agents and Chemotherapy|December 28, 2007
Tipranavir (TPV) genotypic inhibitory quotient predicts virological response at 48 weeks to TPV-based salvage regimensDaniel Gonzalez de Requena, Stefano Bonora, Andrea Calcagno, et al.
Emerging Infectious Diseases|January 27, 2016
Louseborne Relapsing Fever among East African Refugees, Italy, 2015Anna Lucchini, Filippo Lipani, Cecilia Costa, et al.
The Journal of Infectious Diseases|June 2, 2011
Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunctionSudeep P Pushpakom, Neill J Liptrott, Sonia Rodríguez-Nóvoa, et al.
The Journal of Antimicrobial Chemotherapy|November 23, 2019
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trialLaura Dickinson, Rohan Gurjar, Wolfgang Stöhr, et al.
Antiviral Therapy|June 21, 2011
Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new scoreAndrea De Luca, Simona Di Giambenedetto, Renato Maserati, et al.
Pageof 36

Showing results (291-300 of 358) with videos related to

Sort By:
Pageof 36
Antioxidants (Basel, Switzerland)|May 27, 2023
COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress GeneticsJessica Cusato, Alessandra Manca, Alice Palermiti, et al.
Pharmaceuticals (Basel, Switzerland)|December 30, 2020
Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIVAmedeo De Nicolò, Alice Ianniello, Micol Ferrara, et al.
Pharmaceuticals (Basel, Switzerland)|May 28, 2022
Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene VariantsJessica Cusato, Alice Palermiti, Alessandra Manca, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2025
The cerebrospinal fluid virome in people with HIV: links to neuroinflammation and cognitionMattia Trunfio, Rossana Scutari, Valeria Fox, et al.
Frontiers in Microbiology|November 20, 2025
The cerebrospinal fluid virome in people with HIV: links to neuroinflammation and cognitionMattia Trunfio, Rossana Scutari, Valeria Fox, et al.
Antimicrobial Agents and Chemotherapy|December 28, 2007
Tipranavir (TPV) genotypic inhibitory quotient predicts virological response at 48 weeks to TPV-based salvage regimensDaniel Gonzalez de Requena, Stefano Bonora, Andrea Calcagno, et al.
Emerging Infectious Diseases|January 27, 2016
Louseborne Relapsing Fever among East African Refugees, Italy, 2015Anna Lucchini, Filippo Lipani, Cecilia Costa, et al.
The Journal of Infectious Diseases|June 2, 2011
Genetic variants of ABCC10, a novel tenofovir transporter, are associated with kidney tubular dysfunctionSudeep P Pushpakom, Neill J Liptrott, Sonia Rodríguez-Nóvoa, et al.
The Journal of Antimicrobial Chemotherapy|November 23, 2019
Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: a sub-study of the NEAT001/ANRS143 randomized trialLaura Dickinson, Rohan Gurjar, Wolfgang Stöhr, et al.
Antiviral Therapy|June 21, 2011
Interpretation of genotypic HIV-1 resistance to darunavir and virological response: validation of available systems and of a new scoreAndrea De Luca, Simona Di Giambenedetto, Renato Maserati, et al.
Pageof 36